Doxorubicin (Starpharma Holdings)

N/A

Report date: 2026/01/26 13:50:58

Base Information

Drug NameDoxorubicin (Starpharma Holdings)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitorsDNA intercalators
TargetsVirus DNA polymeraseDNATopoisomerase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStarpharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStarpharma Pty Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A